✦HEALTH · 30% off Purgo Labs✦

Verification check

Can You Buy CBL-514?

No. The drug in the trials is only given to trial participants. Vials are already being sold online under the name, and the company's own paperwork shows why none of them can be checked against the real thing.

Read and checked on 17 November 2026. Research reference only. This page is not medical advice and gives no instructions for use.

What it is
An investigational fat-reduction injection from Caliway Biopharmaceuticals, in Phase 3
Active ingredients
Curcumin and trans-resveratrol, named in Caliway's CBL-0203 protocol
Where the real product is
Inside registered clinical trials only
What we found for sale
Three online listings, opened 17 November 2026, with three different descriptions

The short answer

CBL-514 went around social media this week as a new fat-loss peptide. It is not a peptide and it is not on sale. It is a trial drug made by one company, Caliway Biopharmaceuticals, and the only people receiving it are enrolled in that company's studies.

That has not stopped research-chemical sites from listing vials under the name. We opened three of those listings and read them against the one document that says what the product contains, which is Caliway's own study protocol on the US trial registry.

What the company says is in it

The protocol for study CBL-0203, dated 18 October 2021, gives the name of the active ingredient as curcumin and trans-resveratrol. It lists the registry numbers for both compounds. Curcumin is the yellow pigment in turmeric and resveratrol is found in grape skins. The same protocol reports yellow discolouration at the injection site as one of the reactions seen in earlier groups.

What the protocol does not give is the recipe. The concentration of each ingredient is blacked out in the public copy, and nothing is said about what else is in the vial to make two compounds that barely dissolve in water injectable. The product is described as a liquid for injection under the skin, made from a powder.

So the ingredients are public and the formula is not. That distinction is the whole problem for anyone trying to buy it.

What is being sold under the name

These are the three listings as they read on 17 November 2026. None is a vendor we score.

SellerWhat is listedHow it describes the productTesting claim
Biotech Compounds60 mg vial, $100Calls it a synthetic small molecule and says it is not a peptideClaims 99% purity by HPLC with a certificate for every lot
Pure Peptide FactoryKits of ten vials at 5, 10 or 20 mg, $90 to $220Calls it a peptide in the page title and describes a RIPK1, RIPK3 and MLKL pathwayStates a batch purity of 98.9%. The certificate links on the page led nowhere when we read it
USA Performance Aminos20 mg vial, $89, out of stockCalls it a research peptideNo certificate shown on the listing

The three do not agree with each other. One says small molecule, two say peptide. One describes a cell-death pathway that appears nowhere in the published trial papers, which describe apoptosis. The vial sizes run from 5 mg to 60 mg. None of the listings names curcumin or resveratrol.

Two of the three quote a single purity percentage. A single figure can describe one compound. It cannot describe a product whose maker says it has two active ingredients in a set proportion.

Why no certificate can settle it

When we score a vendor we look for a lab report that names the compound, carries the lot number on the vial and can be confirmed with the lab that issued it. For a peptide that works, because the identity of a peptide is its sequence and a lab can measure that directly.

For CBL-514 the identity is a formulation. A lab could find and measure curcumin and resveratrol in a vial. It could not say the amounts are right, because the right amounts have never been published. A report that says 99% tells you nothing about which of the two was measured or whether the other is there at all.

A seller could have a real report from a real lab and it would still only describe the vial. It would not connect that vial to the product that produced the trial results.

What this means if you were looking for it

The trial results people are quoting belong to Caliway's product, given in a clinic under a study protocol. They do not transfer to a vial with the same name on the label. If the science interests you, the CBL-514 explainer sets out what the studies found and what is still unknown.

For compounds that can be checked, our vendor scoreboard shows which sellers publish lab reports that hold up at the lab, and the guide on how to read a lab certificate explains how to run the same checks yourself.

Questions

Can you buy CBL-514?

Not the drug in the trials. CBL-514 is an investigational product from Caliway Biopharmaceuticals and it is supplied only to people enrolled in its clinical studies. Vials sold online under the name are something else, and nobody outside the company can show that they match it.

Is CBL-514 a peptide?

No. Caliway's own study protocol names curcumin and trans-resveratrol as the active ingredients. Both are small plant-derived molecules. A listing that calls it a peptide is describing something other than the trial product.

Can a lab test confirm a vial is CBL-514?

A lab can tell you what is in a vial. It cannot tell you the vial matches the trial drug, because the amounts of each ingredient and the rest of the formula are blacked out in the public protocol. There is nothing to compare the result against.

What would a real certificate for this product need to show?

At the least it would report each of the two active ingredients separately, since one purity figure cannot describe a mixture of two compounds. It would also carry a lot number and a way to confirm the report with the lab that issued it. Even then it would only describe the vial.

Is anyone on the Compound Review scoreboard selling CBL-514?

The three listings we opened on 17 November 2026 are not from vendors we score. If a scored vendor lists it we will note that on its review, because a product that cannot be verified is a mark against the claim that everything is tested.

When could CBL-514 be approved?

Two Phase 3 trials are under way and the registry gives estimated primary completion dates of July and August 2027. Neither trial has reported results. Any approval date is a guess until they do.

Sources

  1. Caliway Biopharmaceuticals, CBL-0203 protocol version 1.0, 18 October 2021, posted on ClinicalTrials.gov (NCT05234736)
  2. Lorenc ZP and others. Randomized Phase 2b Trial of CBL-514 Injection for Abdominal Subcutaneous Fat Reduction. Aesthetic Surgery Journal, 2026. PMID 42159040
  3. Gold M and others. Efficacy and Safety of CBL-514 Injection in Reducing Abdominal Subcutaneous Fat, Phase II. Aesthetic Surgery Journal, 2025. PMID 40037659
  4. ClinicalTrials.gov. SUPREME-01, NCT07140939
  5. ClinicalTrials.gov. SUPREME-02, NCT07526974
  6. Biotech Compounds, CBL-514 listing, read 17 November 2026
  7. Pure Peptide Factory, CBL-514 listing, read 17 November 2026
  8. USA Performance Aminos, CBL-514 listing, read 17 November 2026

Related Guides